Circulating Secretory Phospholipase A2 Activity Predicts Recurrent Events in Patients With Severe Acute Coronary Syndromes
Ziad Mallat, MD, PhD*,*,
Ph. Gabriel Steg, MD, PhD ,
Joëlle Benessiano, MD, PhD ,
Marie-Laure Tanguy, PhD ,
Keith A. Fox, FESC||,
Jean-Philippe Collet, MD, PhD¶,
Omar H. Dabbous, MD, MPH#,
Patrick Henry, MD**,
Kathryn F. Carruthers, MPhil||,
Anne Dauphin, MSc ,
Carla Sibella Arguelles, MSc ,
Joëlle Masliah, PhD ,
Bénédicte Hugel, PhD ,
Gilles Montalescot, MD, PhD¶,
Jean-Marie Freyssinet, PhD ,
Bernard Asselain, PhD and
Alain Tedgui, PhD*
* Institut National de la Santé et la Recherche Médicale, (INSERM U541), Institut Fédératif de Recherche (IRF) "Circulation," Paris, France
Service de Cardiologie, Hôpital Bichat, Paris, France
Centre dInvestigation Clinique, CIC 07, Hôpital Bichat, Paris, France
Département de Biostatistiques, Institut Curie, Paris, France
¶ Service de Cardiologie, Hôpital Pitié-Salpêtrière, Paris, France
** Service de Cardiologie, Hôpital Lariboisière, Paris, France
 Service de Biochimie, Hôpital St. Antoine, Paris, France
 Institut dHématologie et dImmunologie, Faculté de Médecine, Université Louis Pasteur, Strasbourg, and INSERM U143, Le Kremlin-Bicêtre, France
|| Cardiovascular Research Unit, Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom
# University of Massachusetts Medical School, Worcester, Massachusetts

View larger version (18K):
[in a new window]
|
Figure 1 Kaplan-Meier curves showing the cumulative incidence of death or myocardial infarction (MI) according to the tertile of secretory type II phospholipase A2 (PLA2) activity.
|
|
|